Literature DB >> 21858496

Analysis of doxorubicin uptake in single human leukemia K562 cells using capillary electrophoresis coupled with laser-induced fluorescence detection.

Bin Deng1, Zhiming Wang, Jian Song, Yuxiu Xiao, Dan Chen, Jun Huang.   

Abstract

The doxorubicin (DOX) uptake in single human leukemia K562 cells with changes in both drug dosage and exposure period was studied using capillary electrophoresis (CE) coupled with laser-induced fluorescence (LIF) detection. The cells were treated with DOX at different concentrations (1, 3, 10, 20, 30, and 50 μM) and for different exposure times (1, 3, 5, 24, and 48 h). At least 20 cells were analyzed for each DOX-treated cell population. A marked heterogeneity in DOX uptake among single cells was observed, because the relative standard deviation of the uptake of DOX by single cells ranged from 24.0% to 61.1% within each cell population. The cell-to-cell heterogeneity in DOX uptake first decreased and then became constant with increasing drug concentration, but it did not exhibit regular variation with increasing exposure time. The mean DOX uptake was a linear function of drug concentration (r≥0.9667). In terms of the correlation with exposure time, the mean DOX uptake reached its maximum at 3 h for the cell populations treated with 1-10 μM DOX, while it kept increasing during 48 h exposure of cell populations to 20-50 μM DOX. Because it eliminates DOX fluorescence quenching and sample loss, the CE-LIF method directly detects the true DOX uptake by single cells, and thus presents accurate information on both the cell-to-cell heterogeneity in DOX uptake and the patterns of DOX uptake in K562 cells as functions of drug concentration and exposure time. © Springer-Verlag 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858496     DOI: 10.1007/s00216-011-5315-6

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  4 in total

Review 1.  Design and Application of Sensors for Chemical Cytometry.

Authors:  Brianna M Vickerman; Matthew M Anttila; Brae V Petersen; Nancy L Allbritton; David S Lawrence
Journal:  ACS Chem Biol       Date:  2018-02-08       Impact factor: 5.100

2.  A Flow Cytometric Clonogenic Assay Reveals the Single-Cell Potency of Doxorubicin.

Authors:  Katie F Maass; Chethana Kulkarni; Mohiuddin A Quadir; Paula T Hammond; Alison M Betts; Karl Dane Wittrup
Journal:  J Pharm Sci       Date:  2015-09-07       Impact factor: 3.534

3.  Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma in vitro and in vivo.

Authors:  Laura Patras; Aura Elena Ionescu; Cristian Munteanu; Renata Hajdu; Andreea Kosa; Alina Porfire; Emilia Licarete; Valentin Florian Rauca; Alina Sesarman; Lavinia Luput; Paul Bulzu; Paul Chiroi; Rares Andrei Tranca; Marta-Szilvia Meszaros; Giorgiana Negrea; Lucian Barbu-Tudoran; Monica Potara; Stefan Szedlacsek; Manuela Banciu
Journal:  Cancer Biol Ther       Date:  2021-12-29       Impact factor: 4.742

4.  An "eat me" combinatory nano-formulation for systemic immunotherapy of solid tumors.

Authors:  Hend Mohamed Abdel-Bar; Adam A Walters; Yau Lim; Nadia Rouatbi; Yue Qin; Fatemeh Gheidari; Shunping Han; Rihab Osman; Julie Tzu-Wen Wang; Khuloud T Al-Jamal
Journal:  Theranostics       Date:  2021-08-11       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.